“SWIFT-seq is a powerful option as it can measure the number of CTCs, characterize the genomic alterations of the tumor, ...

Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Panelists discuss the anticipated 2026 updates to the American Academy of Dermatology guidelines for hidradenitis suppurativa ...

Patients with chronic lymphocytic leukemia (CLL) had significantly lower monocyte-to-lymphocyte ratio values compared with ...

Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...

The American Society for Preventive Cardiology (ASPC) marked its 40th anniversary this year at the ASPC Congress on CVD ...

In advanced non–small cell lung cancer (NSCLC), discontinuing immunotherapy after 2 years can maintain durable responses ...

The humanized IgG4 monoclonal antibody was first approved for myasthenia gravis in the US in 2023, with approvals in Japan ...

Making treatment for non–small cell lung cancer (NSCLC) accessible to a wide range of the population can help to improve ...

A qualitative study found strong support for primary care provider–nephrologist comanagement of chronic kidney disease (CKD), ...